Apyx Medical Corporation (APYX), an advanced energy technology company, announced on Monday that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration or FDA for its AYON Body Contouring System.
AYON Body Contouring System is designed to be the first all-in-one solution for comprehensive body contouring in the surgical suite. This system integrates advanced modalities to address multiple aspects of body contouring, including fat removal, tissue contraction, and aesthetic enhancement.
Later this year, Apyx plans to submit an additional 510(k) for power-assisted liposuction indications, expanding the system's capabilities.
Currently, APYX is trading at $1.71 up by 1.27%.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.